LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

Начало・Списък с акции・Simulations Plus Inc

Simulations Plus Inc

Затворен

СекторЗдравеопазване

15.14 4.78

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

13.88

Максимум

15.26

Ключови измерители
By Trading Economics
Приходи	3.9M 4.5M
Продажби	5.9M 24M
EPS	0.35
Дивидентна доходност	0.48
Марж на печалбата	18.669
Служители	212
EBITDA	4.9M 7.2M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+10.57% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	0.48% 2.39%
Следващи печалби	13.07.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	27M 278M
Предишно отваряне	10.36
Предишно затваряне	15.14

Настроения в новините

By Acuity

56%

44%

280 / 345 Класиране в Healthcare

Simulations Plus Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

21.05.2026 г., 22:48 ч. UTC

Придобивния, сливания и поглъщания

Conduent to Sell Public Transit Business to Modaxo for $164 Million

21.05.2026 г., 16:49 ч. UTC

Печалби

Walmart's Fuel Business Benefits from Rising U.S. Gas Prices, Though Volume Per Transaction Falls -- OPIS

21.05.2026 г., 16:26 ч. UTC

Значими двигатели на пазара

Spotify Technology Shares Up Amid New AI Tool For Remixing Songs

21.05.2026 г., 23:51 ч. UTC

Пазарно говорене

Nikkei Might Rise on Continued Hopes for Possible U.S.-Iran Deal -- Market Talk

21.05.2026 г., 23:37 ч. UTC

Печалби

Lenovo Group 4Q Oper Profit $886.0M Vs. $331.0M >0992.HK

21.05.2026 г., 23:37 ч. UTC

Печалби

Lenovo Group 4Q Rev $21.60B Vs. $16.98B >0992.HK

21.05.2026 г., 23:37 ч. UTC

Печалби

Lenovo Group 4Q Net $521.0M Vs. Net $90.0M >0992.HK

21.05.2026 г., 23:34 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Mixed Sentiment -- Market Talk

21.05.2026 г., 23:30 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

21.05.2026 г., 23:30 ч. UTC

Пазарно говорене

Napier Port Loses Bull Despite Robust 1H Result -- Market Talk

21.05.2026 г., 22:33 ч. UTC

Придобивния, сливания и поглъщания

Conduent to Sell Public Transit Business to Modaxo for $164M

21.05.2026 г., 21:53 ч. UTC

Печалби

Marvell Stock Notches Its 15th Record Closing High This Year -- Barrons.com

21.05.2026 г., 21:02 ч. UTC

Печалби

These Stocks Are Today's Movers: Nvidia, IBM, Rigetti, Nebius, Bloom Energy, Applied Digital, Intuit, D-Wave, Spotify, and More -- Barrons.com

21.05.2026 г., 20:55 ч. UTC

Печалби

Walmart Sales Rise as It Navigates Higher Fuel Prices -- 2nd Update

21.05.2026 г., 20:30 ч. UTC

Горещи акции

Stocks to Watch Recap: Nvidia, Spotify, Stellantis, Intuit -- WSJ

21.05.2026 г., 20:20 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

21.05.2026 г., 20:20 ч. UTC

Пазарно говорене

Mexico's Revised 1Q GDP Seen Confirming Contraction -- Market Talk

21.05.2026 г., 20:20 ч. UTC

Печалби

Webull 1Q Adj EPS 3c >BULL

21.05.2026 г., 20:20 ч. UTC

Печалби

Webull 1Q Rev $159.9M >BULL

21.05.2026 г., 20:18 ч. UTC

Пазарно говорене

Mexico's Inflation Seen Easing in Early May -- Market Talk

21.05.2026 г., 20:18 ч. UTC

Печалби

Webull 1Q Loss/Shr 4c

21.05.2026 г., 19:43 ч. UTC

Пазарно говорене

Oil Futures Lose Ground on Hopes for U.S.-Iran Deal -- Market Talk

21.05.2026 г., 19:33 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Edge Up in Steady Trading -- Market Talk

21.05.2026 г., 18:58 ч. UTC

Печалби

Nvidia Is Now the Megacap Cash Machine, and Big Tech Is Footing the Bill -- Barrons.com

21.05.2026 г., 18:15 ч. UTC

Пазарно говорене

Gold Higher For Second Consecutive Day -- Market Talk

21.05.2026 г., 17:40 ч. UTC

Пазарно говорене

Prolonged War Putting Energy Normalcy Further Away -- Market Talk

21.05.2026 г., 17:04 ч. UTC

Пазарно говорене

SpaceX Revealed as Top 10 Bitcoin Holder -- Market Talk

21.05.2026 г., 17:01 ч. UTC

Печалби

These Stocks Are Today's Movers: Nvidia, IBM, Rigetti, GlobalFoundries, Nebius, Applied Digital, Intuit, Spotify, and More -- Barrons.com

21.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Печалби

Stellantis Targets Distant but Constructive -- Market Talk

21.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Simulations Plus Inc Прогноза

Ценова цел

By TipRanks

10.57% нагоре

12-месечна прогноза

Среден 16 USD 10.57%

Висок 16 USD

Нисък 16 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Simulations Plus Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

3 ratings

Купи

Задържане

Продай

Според 3 анализатори, дали борсови рейтинги на Simulations Plus Inc през последните 3 месеца.

Настроение

By Acuity

280 / 345 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.